Takeda Ventures (TVI) is the corporate investment arm of Takeda Pharmaceuticals. It invests in current and future areas of interest for Takeda Pharmaceuticals. As a strategic investor, TVI aims to provide support and guidance to entrepreneurs and early-stage companies driving concepts through clinical proof of concept. Takeda Ventures also strives to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world. It invests in early-stage opportunities that complement Takedas pipeline and products. TVI's mission is to create strategic growth opportunities for Takeda by investing and nurturing Innovative Life Science Companies in areas aligned with Takedas R&D focuses which include; Oncology, Gastroenterology, Neuroscience, and Rare Disease. TVI's aim is to access and support therapeutic and platform innovation working closely with academic innovator, entrepreneurs and investors. It invest in seeds or syndicated venture investing providing to the companies access to the resources of a multinational pharmaceutical company.